Get 40% Off
💰 Warren Buffett reveals a $6.72 billion stake in ChubbCopy Portfolios

Pre-Open Stock Movers: Bristol-Myers Jumps on FDA Approval, Carvana Gains on Upgrade

Published 09/12/2022, 08:44 AM
Updated 09/12/2022, 08:46 AM
© Reuters.  Pre-Open Stock Movers: Bristol-Myers Jumps on FDA Approval, Carvana Gains on Upgrade
ADBE
-
UNP
-
APA
-
BMY
-
SPPI
-
CVNA
-
BILL
-
RLAY
-
RBLX
-

Pre-Open Stock Movers:

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) 18% HIGHER; announced data from a poster presentation titled: High Activity of Poziotinib in G778_P780dup HER2 Exon 20 Insertion Mutations in Non-Small Cell Lung Cancer (NSCLC). The data show that poziotinib is highly active in G778 mutations in both treatment-naive and previously treated patients with NSCLC.

Carvana (NYSE:CVNA) 8% HIGHER; Piper Sandler upgraded from Neutral to Overweight with a price target of $73.00 (from $98.00).

Bristol-Myers Squibb (NYSE:BMY) 7% HIGHER; U.S. FDA approved Deucravacitinib, now known as Sotyktu, for the treatment of psoriasis.

Relay Therapeutics, Inc. (NASDAQ:RLAY5% LOWER; commenced an underwritten public offering of $300.0 million of shares of its common stock. Relay Therapeutics also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the shares of common stock offered in the public offering. All of the shares in the proposed offering are to be sold by Relay Therapeutics.

Bill.com Holdings Inc. (NYSE:BILL) 3% HIGHER; Morgan Stanley initiates coverage with an Overweight rating and a price target of $220.00.

Apache Corp. (NASDAQ:APA) 3% HIGHER; Citi upgraded from Neutral to Buy with a price target of $58.00 (from $40.00).

Union Pacific  (NYSE:UNP) 2% HIGHER; BofA Securities upgraded from Neutral to Buy with a price target of $260.00.

Adobe (NASDAQ:ADBE) 2% LOWER; Mizuho Securities downgraded from Buy to Neutral with a price target of $440.00 (from $480.00).

Roblox Corp. (NYSE:RBLX2% LOWER; Cowen initiates coverage with an Underperform rating and a price target of $31.00.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.